CytoDyn Inc.·4

Jun 8, 4:06 PM ET

Recknor Chris P 4

4 · CytoDyn Inc. · Filed Jun 8, 2022

Insider Transaction Report

Form 4
Period: 2022-03-31
Recknor Chris P
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2022-03-31+12,950699,000 total
  • Award

    Common Stock

    2022-04-15+17,746716,746 total
Footnotes (1)
  • [F1]Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Documents

2 files